FDA approves Purdue Pharma’s controversial new overdose-reversal medication
Purdue Pharma, the company best known for fueling the opioid crisis by misleadingly marketing the infamous painkiller OxyContin, received approval on Wednesday for a new auto-injector device used to reverse opioid overdoses, the company said.
Purdue’s announcement represents the latest in a string of recent approvals for products that use nalmefene, essentially a more powerful version of its better-known chemical cousin, naloxone.
Read Original Article: FDA approves Purdue Pharma’s controversial new overdose-reversal medication »
